Work

NEXT: A single-arm, phase 2, open-label study of adjuvant nivolumab after completion of chemo-radiation therapy in patients with localized muscle-invasive bladder cancer.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.6_suppl.506

Authors: Sumati Gupta, G. Daniel Grass, Benjamin L. Maughan, Rohit K. Jain, Christopher B. Dechet, Alejandro Sanchez, Brock O Neil, Michael Adam Poch, Roger Li, Shane Lloyd, Jonathan David Tward, Tenzin Kunsang Phunrab, Josiah Hawks, Umang Swami, Kenneth M Boucher, Neeraj Agarwal

Institutions: University of Utah, Huntsman Cancer Institute, Moffitt Cancer Center

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4212939704

Cites:

Cited by: 4

Related to: 10